Cytokine stimulation of T lymphocytes regulates their capacity to induce monocyte production of tumor necrosis factor-alpha, but not interleukin-10: Possible relevance to pathophysiology of rheumatoid arthritis

被引:142
作者
Sebbag, M [1 ]
Parry, SL [1 ]
Brennan, FM [1 ]
Feldmann, M [1 ]
机构
[1] KENNEDY INST,LONDON W6 8LH,ENGLAND
关键词
interleukin-15; rheumatoid arthritis; tumor necrosis factor-alpha; cell contact; cytokine activation;
D O I
10.1002/eji.1830270308
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Previous studies in the laboratory have shown that the pro-inflammatory cytokine tumor necrosis factor (TNF)-alpha plays a pivotal role in the pathogenesis of rheumatoid arthritis (RA). The mechanisms involved in regulating monocyte/macrophage cytokine production are not yet fully understood, but are thought to involve both soluble factors and cell/cell contact with other cell types. We and others have previously demonstrated that T cells activated through the T cell receptor/CD3 complex induce monocyte TNF-alpha production by contact-mediated signals. In this report, we investigated further whether T cells activated by cytokines in the absence of T cell receptor stimulation also regulate monocyte cytokine production. T cells were activated in an antigen-independent manner using the cytokines interleukin (IL)-15 or IL-2 alone, or in combination with IL-6 and TNF-alpha. Subsequently, T cells were fixed and incubated with monocytes. Fixed, cytokine-stimulated T cells induced monocytes to secrete TNF-alpha in a dose-dependent manner, but did not induce secretion of IL-10, a potent endogenous down-regulator of TNF-alpha and other pro-inflammatory cytokines. Stimulation of monocyte TNF-alpha was markedly inhibited when T cells were physically separated from monocytes within the tissue culture well, confirming that T cell contact is necessary. T cell acquisition of monocyte-activating capacity was shown to be dependent on the period of cytokine stimulation, with T cells activated for 8 days more effective than T cells activated for shorter periods. Addition of interferon-gamma or granulocyte/macrophage colony-stimulating factor to the T cell/monocyte cultures enhanced T cell induction of monocyte TNF-alpha by threefold and ninefold, respectively The results from this model of cognate interaction suggest that cytokine-stimulated T cells, interacting with macrophages in the rheumatoid synovial membrane, may contribute to the continuous excessive production of TNF-alpha observed in the RA joint, and to the imbalance of pro-inflammatory cytokines over anti-inflammatory cytokines.
引用
收藏
页码:624 / 632
页数:9
相关论文
共 55 条
  • [1] STRATEGIES OF ANTICYTOKINE MONOCLONAL-ANTIBODY DEVELOPMENT - IMMUNOASSAY OF IL-10 AND IL-5 IN CLINICAL-SAMPLES
    ABRAMS, JS
    RONCAROLO, MG
    YSSEL, H
    ANDERSSON, U
    GLEICH, GJ
    SILVER, JE
    [J]. IMMUNOLOGICAL REVIEWS, 1992, 127 : 5 - 24
  • [2] CD40 EXPRESSION BY HUMAN MONOCYTES - REGULATION BY CYTOKINES AND ACTIVATION OF MONOCYTES BY THE LIGAND FOR CD40
    ALDERSON, MR
    ARMITAGE, RJ
    TOUGH, TW
    STROCKBINE, L
    FANSLOW, WC
    SPRIGGS, MK
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (02) : 669 - 674
  • [3] Interferon-alpha stimulates production of interleukin-10 in activated CD4(+) T cells and monocytes
    Aman, MJ
    Tretter, T
    Eisenbeis, I
    Bug, G
    Decker, T
    Aulitzky, WE
    Tilg, H
    Huber, C
    Peschel, C
    [J]. BLOOD, 1996, 87 (11) : 4731 - 4736
  • [4] BUCHAN G, 1988, CLIN EXP IMMUNOL, V73, P449
  • [5] DIFFERENTIAL EXPRESSION OF IA ANTIGENS BY RHEUMATOID SYNOVIAL LINING CELLS
    BURMESTER, GR
    JAHN, B
    ROHWER, P
    ZACHER, J
    WINCHESTER, RJ
    KALDEN, JR
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1987, 80 (03) : 595 - 604
  • [6] Triggering of CD23b antigen by anti-CD23 monoclonal antibodies induces interleukin-10 production by human macrophages
    Dugas, N
    Vouldoukis, I
    Becherel, P
    Arock, M
    Debre, P
    Tardieu, M
    Mossalayi, DM
    Delfraissy, JF
    Kolb, JP
    Dugas, B
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (06) : 1394 - 1398
  • [7] DUKE O, 1982, CLIN EXP IMMUNOL, V49, P22
  • [8] RANDOMIZED DOUBLE-BLIND COMPARISON OF CHIMERIC MONOCLONAL-ANTIBODY TO TUMOR-NECROSIS-FACTOR-ALPHA (CA2) VERSUS PLACEBO IN RHEUMATOID-ARTHRITIS
    ELLIOTT, MJ
    MAINI, RN
    FELDMANN, M
    KALDEN, JR
    ANTONI, C
    SMOLEN, JS
    LEEB, B
    BREEDVELD, FC
    MACFARLANE, JD
    BIJL, H
    WOODY, JN
    [J]. LANCET, 1994, 344 (8930) : 1105 - 1110
  • [9] ELLIOTT MJ, 1993, ARTHRITIS RHEUM, V36, P1681, DOI 10.1002/art.23362
  • [10] REPEATED THERAPY WITH MONOCLONAL-ANTIBODY TO TUMOR-NECROSIS-FACTOR-ALPHA (CA2) IN PATIENTS WITH RHEUMATOID-ARTHRITIS
    ELLIOTT, MJ
    MAINI, RN
    FELDMANN, M
    LONGFOX, A
    CHARLES, P
    BIJL, H
    WOODY, JN
    [J]. LANCET, 1994, 344 (8930) : 1125 - 1127